Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer

Treatment options for triple negative breast cancer (TNBC) are generally limited to cytotoxic chemotherapy. Recently, anti-epidermal growth factor receptor (EGFR) therapy has been introduced for TNBC patients. We engineered a novel nanobioconjugate based on a poly(β-L-malic acid) (PMLA) nanoplatform...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Satoshi, Patil, Rameshwar, Portilla-Arias, Jose, Ding, Hui, Konda, Bindu, Espinoza, Andres, Mongayt, Dmitriy, Markman, Janet L., Elramsisy, Adam, Phillips, H. Westley, Black, Keith L., Holler, Eggehard, Ljubimova, Julia Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280290/
https://www.ncbi.nlm.nih.gov/pubmed/22355336
http://dx.doi.org/10.1371/journal.pone.0031070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280290/
https://www.ncbi.nlm.nih.gov/pubmed/22355336
http://dx.doi.org/10.1371/journal.pone.0031070

Ejemplares similares